Bioprocess design and economics of recombinant BM86/BM95 antigen production for anti-tick vaccines

Biochemical Engineering Journal

Volumn 52, Issue 1, 2010, Pages 79-90

  Canales, Mario ^a   Moreno Cid, Juan A ^a   Almazán, Consuelo ^b   Villar, Margarita ^a   de la Fuente, José ^a,c  

^a INSTITUTO DE INVESTIGACIÓN EN RECURSOS CINEGÉTICOS IREC CSIC UCLM JCCM   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE TAMAULIPAS   (Mexico)

^c OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Bioprocess economics; Bm86; Bm95; Boophilus microplus; Pichia pastoris; Tick

Indexed keywords

BIOPROCESS ECONOMICS; BM86; BM95; BOOPHILUS MICROPLUS; PICHIA PASTORIS; TICK;

ANTIGENS; DNA; ECONOMIC ANALYSIS; ESCHERICHIA COLI; GENETIC ENGINEERING; PROTEINS; TECHNOLOGY;

VACCINES;

BM86 ANTIGEN; BM95 MSP1A ANTIGEN; RECOMBINANT ANTIGEN; UNCLASSIFIED DRUG; VACCINE;

ARTICLE; BACTERIAL MEMBRANE; BIOPROCESS; BOOPHILUS MICROPLUS; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG SAFETY; ESCHERICHIA COLI; NONHUMAN; PICHIA PASTORIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SENSITIVITY ANALYSIS; VACCINE PRODUCTION;

BOOPHILUS; BOOPHILUS MICROPLUS; BOS; ESCHERICHIA COLI; IXODIDA; PICHIA PASTORIS; RHIPICEPHALUS;

EID: 77956264331     PISSN: 1369703X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bej.2010.07.008     Document Type: Article

References (86)

1. de la Fuente J., Estrada-Peña A., Venzal J.M., Kocan K.M., Sonenshine D.E. Overview: ticks as vectors of pathogens that cause disease in humans and animals. F. Biosci. 2008, 13:6938-6946.
2. Piper E.K., Jackson L.A., Bagnall N.H., Kongsuwan K.K., Lew A.E., Jonsson N.N. Gene expression in the skin of Bos taurus and Bos indicus cattle infested with the cattle tick, Rhipicephalus (Boophilus) microplus. Vet. Immunol. Immunopathol. 2008, 126:110-119.
3. de la Fuente J., Almazan C., Canales M., Perez de la Lastra J.M., Kocan K.M., Willadsen P. A ten-year review of commercial vaccine performance for control of tick infestations on cattle. Animal Health Res. Rev. 2007, 8:23-28.
4. de laFuente J., Rodriguez M., Montero C., Redondo M., Garcia-Garcia J.C., Mendez L., Serrano E., Valdes M., Enriquez A., Canales M., Ramos E., Boué O., Machado H., Lleonart R. Vaccination against ticks (Boophilus spp.): the experience with the Bm86-based vaccine Gavac™. Genet. Anal. Biomol. Eng. 1999, 15:143-148.
5. Rajput Z.I., Hu S.-H., Chen W.-J., Arijo A.G., Xiao C.-W. Importance of ticks and their chemical and immunological control in livestock. J. Zhejiang Univ. Sci. B 2006, 7:912-921.
6. de la Fuente J., Rodriguez M., Redondo M., Montero C., Garcia-Garcia J.C., Mendez L., Serrano E., Valdes M., Enriquez A., Canales M., Ramos E., Boué O., Machado H., Lleonart R., de Armas C.A., Rey S., Rodriguez J.L., Artiles M., Garcia L. Field studies and cost-effectiveness analysis of vaccination with Gavac™ against the cattle tick Boophilus microplus. Vaccine 1998, 16:366-373.
7. de la Fuente J., Kocan K.M. Advances in the identification and characterization of protective antigens for recombinant vaccines against tick infestations. Expert Rev. Vaccines 2003, 2:583-593.
8. Ghosh S., Azhahianambi P., Yadav M.P. Upcoming and future strategies of tick control: a review. J. Vect. Borne Dis. 2007, 44:79-89.
9. Willadsen P., Smith D., Cobon G., McKenna R.V. Comparative vaccination of cattle against Boophilus microplus with recombinant antigen Bm86 alone or in combination with recombinant Bm91. Parasite Immunol. 1996, 18:241-246.
10. de la Fuente J., Kocan K.M. Strategies for development of vaccines for control of ixodid tick species. Parasite Immunol. 2006, 28:275-283.
11. de la Fuente J., Almazan C., Blouin E.F., Naranjo V., Kocan K.M. Reduction of tick infestations with Anaplasma marginale and A. phagocytophilum by targeting the tick protective antigen subolesin. Parasitol. Res. 2006, 100:85-91.
12. Willadsen P. Tick control: thoughts on a research agenda. Vet. Parasitol. 2006, 138:161-168.
13. Canales M., Perez de la Lastra J.M., Naranjo V., Nijhof A.M., Hope M., Jongejan F., de la Fuente J. Expression of recombinant Rhipicephalus (Boophilus) microplus, R. annulatus and R. decoloratus Bm86 orthologs as secreted proteins in Pichia pastoris. BMC Biotechnol. 2008, 8:14.
14. Canales M., Almazan C., Naranjo V., Jongejan F., de de la Fuente J. Vaccination with recombinant Boophilus annulatus Bm86 ortholog protein, Ba86, protects cattle against B. annulatus and B. microplus infestations. BMC Biotechnol. 2009, 9(2009):29.
15. García-García J.C., Montero C., Redondo M., Vargas M., Canales M., Boué O., Rodríguez M., Joglar M., Machado H., Gonzalez I.L., Valdes M., Mendez L., de la Fuente J. Control of ticks resistant to immunization with Bm86 in cattle vaccinated with the recombinant antigen Bm95 isolated from the cattle tick, Boophilus microplus. Vaccine 2000, 18(2000):2275-2287.
16. Patarroyo J.H., Portela R.W., De Castro R.O., Pimentel J.C., Guzman F., Patarroyo M.E., Vargas M.I., Prates A.A., Mendes M.A. Immunization of cattle with synthetic peptides derived from the Boophilus microplus gut protein (Bm86). Vet. Immunol. Immunopathol. 2002, 88:163-172.
17. de la Fuente J., Garcia-Garcia J.C., Blouin E.F., Kocan K.M. Major surface protein 1a effects tick infection and transmission of the ehrlichial pathogen Anaplasma marginale. Int. J. Parasitol. 2001, 31:1705-1714.
18. Canales M., Almazán C., Pérez de la Lastra J.M., de la Fuente J. Anaplasma marginale major surface protein 1a directs cell surface display of tick BM95 immunogenic peptides on Escherichia coli. J. Biotechnol. 2008, 135:326-332.
19. Canales M., Labruna M.B., Soares J.F., Prudencio C.R., de la Fuente J. Protective efficacy of bacterial membranes containing surface-exposed BM95 antigenic peptides for the control of cattle tick infestations. Vaccine 2009, 27:7244-7248.
20. Turnbull I.F., Smith D.R.J., Sharp P.J., Cobon G.S., Hynes M.J. Expression and secretion in Aspergillus nidulans and Aspergillus niger of a cell surface glycoprotein from the cattle tick, Boophilus microplus, by using the fungal amds promoter system. Appl. Environ. Microbiol. 1990, 56:2847-2852.
21. Tellam R.L., Smith D., Kemp D.H., Willadsen P. Vaccinations against ticks. Animal Parasite Control Utilizing Biotechnology 1992, CRC Press, Boca Raton, pp. 303-331. W.K. Yong (Ed.).
22. Rodríguez M., Rubiera R., Montesinos R., Cremata J.A., Falcón V., Sanchez G., Bringas R., Cordovés C., Valdés M., Lleonart R., Herrera L., de la Fuente J. High level expression of the B. microplus Bm86 antigen in the yeast P. pastoris forming highly inmunogenic particles for cattle. J. Biotechnol. 1994, 33:135-146.
23. Canales M., Enriquez A., Ramos E., Cabrera D., Dandie H., Soto A., Falcon V., Rodriguez M., de la Fuente J. Large-scale production in Pichia pastoris of the recombinant vaccine Gavac™ against cattle tick. Vaccine 1997, 15:414-422.
24. Cregg J.M., Barringer K.J., Hessler A.Y., Madden K.R. Pichia pastoris as a host system for transformations. Mol. Cell. Biol. Dec. 1985, 3376-3385.
25. Vedvick T.S. Gene expression in yeast: Pichia pastoris. Curr. Opin. Biotechnol. 1991, 2:742-745.
26. Cregg J.M., Vedvick T.S., Raschke W.C. Recent advances in the expression of foreign genes in Pichia pastoris. Biotechnology 1993, 11:905-910.
27. Cereghino J.L., Cregg J.M. Heterologous protein expression in the methylotrophic yeast Pichia pastoris. FEMS Microbiol. Rev. 2000, 24:45-66.
28. Macauley-Patrick S., Fazenda M.L., McNeil B., Harvey L.M. Heterologous protein production using the Pichia pastoris expression system. Yeast 2005, 22:249-270.
29. Jahic M., Veide A., Charoenrat T., Teeri T., Enfors S.-O. Process technology for production and recovery of heterologous proteins with Pichia pastoris. Biotechnol. Prog. 2006, 22:1465-1473.
30. Dragosits M., Stadlmann J., Albiol J., Baumann K., Maurer M., Gasser B., Sauer M., Altmann F., Ferrer P., Mattanovich D. The Effect of Temperature on the Proteome of Recombinant Pichia pastoris. J. Proteome Res. 2009, 8:1380-1392.
31. Higgins D.R., Cregg J.M. Pichia Protocols 1998, vol. 10. Humana Press, Totowa, NJ.
32. De Schutter K., Lin Y.-C., Tiels P., Van Hecke A., Glinka S., Weber-Lehmann J., Rouzé P., Van de Peer Y., Callewaert N. Genome sequence of the recombinant protein production host Pichia pastoris. Nat. Biotechnol. 2009, 561-566.
33. Cos O., Serrano A., Montesinos J.L., Ferrer P., Cregg J.M., Valero F. Combined effect of the methanol utilization (Mut) phenotype and gene dosage on recombinant protein production in Pichia pastoris fed-batch cultures. J. Biotechnol. 2005, 116:321-335.
34. Chen C.-C., Wu P.-H., Huanga C.-T., Cheng K.-J. A Pichia pastoris fermentation strategy for enhancing the heterologous expression of an Escherichia coli phytase. Enzyme Microb. Technol. 2004, 35:315-320.
35. Damasceno L.M., Pla I., Chang H.-J., Cohen L., Ritter G., Old L.J., Batt C.A. An optimized fermentation process for high-level production of a single-chain Fv antibody fragment in Pichia pastoris. Protein Exp. Purif. 2004, 37:18-26.
36. + strain of Pichia pastoris using an optimized methanol feed profile. Biotechnol. Prog. 2003, 19:794-802.
37. Montesino R., Cremata J.A., Rodríguez M., Besada V., Falcón V., de la Fuente J. Biochemical characterization of the recombinant B. microplus Bm86 antigen obtained from Pichia pastoris expressing cells. Biotechnol. Appl. Biochem. 1996, 23:23-28.
38. Enríquez A., Canales M., Ramos E., Dandie H., Boué O., Soto A., Cabrera D. Production of a recombinant vaccine against Boophilus microplus. Recombinant Vaccines for the Control of Tick 1995, Elfos Scientiae, La Habana, Cuba, pp. 79-103. J. de la Fuente (Ed.).
39. González L.J., Cremata J.A., Guanche Y., Ramos Y., Triguero A., Cabrera G., Montesino R., Huerta V., Pons T., Boué O., Farnós O., Rodríguez M. The cattle tick antigen, Bm95, expressed in Pichia pastoris contains short-chains of N- and O-glycans. Arch. Biochem. Biophys. 2004, 2:205-211.
40. Yong V., González M.E., Herrera L., Delgado J. HIS-3 gene of Saccharomyces cerevisiae complement his mutation in yeast Pichia pastoris. Biotecnología Aplicada 1993, 9:55-61.
41. Canales M., Buxadó J.A., Heynnegnezz L., Enriquez A. Mechanical disruption of Pichia pastoris yeast to recover the recombinant protein Bm86. Enz. Microb. Technol. 1998, 23:58-63.
42. Azhahianambi P., de la Fuente J., Suryanarayana V.V.S., Ghosh S. Cloning, expression and immunoprotective efficacy of rHaa86, the homologue of the Bm86 tick vaccine antigen, from Hyalomma anatolicum anatolicum. Parasite Immunol. 2009, 31:111-122.
43. Baneyx F. Recombinant protein expression in Escherichia coli. Curr. Opin. Biotechnol. 1999, 10:411-421.
44. Care S., Bignon C., Pelissier M.C., Blanc E., Canard B., Coutard B. The translation of recombinant proteins in E. coli can be improved by in silico generating and screening random libraries of a 270/+96 mRNA region with respect to the translation initiation codon. Nucleic Acids Res. 2008, 36:e6.
45. Sorensen H.P., Mortensen K.K. Advanced genetic strategies for recombinant protein expression in Escherichia coli. J. Biotechnol. 2005, 115:113-128.
46. Swartz J.R. Advances in Escherichia coli production of therapeutic proteins. Curr. Opin. Biotechnol. 2001, 12:195-201.
47. Rand K.N., Moore T., Srikantha A., Spring K., Tellam R., Willadsen P., Cobon G.S. Cloning and expression of a protective antigen from the cattle tick Boophilus microplus. Proc. Natl. Acad. Sci. U.S.A. 1989, 86:9657-9661.
48. E. De Bernardez-Clark, G. Georgiou, Inclusion bodies and recovery of proteins from the aggregated state, in: G. Georgiou, E. De Bernardez-Clark (Eds.), ACS, Washington DC, 1991, pp. 1-20.
49. de la Fuente J., García-García J.C., Blouin E.F., Kocan K.M. Differential adhesion of major surface proteins 1a and 1b of the ehrlichial cattle pathogen Anaplasma marginale to bovine erythrocytes and tick cells. Int. J. Parasitol. 2001, 31:145-153.
50. Petrides D. Bioprocess design. Bioseparations Science and Engineering 2002, Oxford University Press, NY, USA, (Chapter 11). R.G. Harrison, P.W. Todd, S.R. Rutge, D. Petrides (Eds.).
51. Atkinson A., Mavituna F. Upstream Processing. Biochemical Engineering and Biotechnology Handbook 1991, 831-872. Macmillan Publishers Ltd., NY, USA. second ed. A. Atkinson, F. Mavituna (Eds.).
52. Wheelwright S.M. The design of downstream processes for large-scale protein purification. J. Biotechnol. 1989, 11:89-102.
53. Asenjo J.A., Herrera L., Byrne B. Development of an expert system for selection and synthesis of protein purification processes. J. Biotechnology 1989, 11:275-298.
54. Asenjo J.A. Selection of operations in separation processes. Separation Processes in Biotechnology 1990, 3-16. Marcel Dekker Inc., New York. J.A. Asenjo (Ed.).
55. Prokopakis G.J., Asenjo J.A. Synthesis of downstream process. Separation Processes in Biotechnology 1990, 571-616. Marcel Dekker Inc., New York. J.A. Asenjo (Ed.).
56. Buxadó J.A., Heynngnezz L.E., Juiz A.G., Tamayo G., Lima I.R., Marshalleck H.D., Mola E.L. Scale-up of processes to isolate the misstargeted rBm86 protein from Pichia pastoris. African J. Biotechnol. 2004, 3:599-605.
57. Boué O., Sanchez K., Tamayo G., Hernandez L., Reytor E., Enriquez A. Single-step purification of recombinant Bm86 protein produced in Pichia pastoris by salting-out and by acid precipitation of contaminants. Biotechnol. Tech. 1997, 11:561-565.
58. P.W. Ormel, América Latina y el Caribe en el contexto mundial de los productos de origen animal: carne vacuna, FAO Santiago de Chile, 2000. http://www.fiagro.org.sv/archivos/1/1037.pdf.
59. Web site of the Governor-General of the Commonwealth of Australia, 2009. http://www.gg.gov.au/governorgeneral/speech.php%3Fid=399.
60. Hearn M.T.W., Anspach B. Chemical, physical and biochemical concepts in isolation and purification of proteins. Separation Processes in Biotechnology 1990, Marcel Dekker Inc., New York, pp. 17-64. J.A. Asenjo (Ed.).
61. Jeanike R. Folding and association of proteins. Prog. Biophys. Mol. Biol. 1987, 49:117-227.
62. Datar R.V., Cartwright T., Rosen C.-G. Process economics of animal cell and bacterial fermentations: a case study analysis of tissue plasminogen activator. Biotechnology 1993, 11:349-357.
63. Datar R., Rosen C.-G. Downstream process economics. Separation Processes in Biotechnology 1990, Marcel Dekker Inc., New York, pp. 741-793. J.A. Asenjo (Ed.).
64. H. Soto, E. Espejel-Savala, H.F. Martínez, La Formulación y Evaluación Técnico-Económica de Proyectos Industriales, Estimación de Costos y Presupuestos de Operación, Editovisual CeNETI, Mexico, 1978 (Chapter 7).
65. Kalk J.P., Langlykke A.F. Cost estimation for biotechnology projects. Manual of Industrial Microbiology and Biotechnology 1990, American Society for Microbiology, Washington D.C., pp. 363-385. A.L. Demain, N.A. Solomon (Eds.).
66. J. de la Fuente, M. Canales, Sistema para la expresión de péptidos sobre la superficie bacteriana, Patent filed at the Oficina Española de Patentes y Marcas, P200801129 (April 16, 2008), PCT/ES2009/070103.
67. Fane A.G., Radovich J.M. Membrane systems. Separation Processes in Biotechnology 1990, 209-262. Marcel Dekker Inc., New York. J.A. Asenjo (Ed.).
68. Cheryan M. Ultrafiltration applications. Ultrafiltration Handbook 1986, Technomic Publishing Co. Inc., Pennsylvania, pp. 231-350.
69. McGregor W.C. Selection and use of ultrafiltration membranes. Membrane Separations in Biotechnology 1986, 1-26. Marcel Dekker Inc., New York. W.C. McGregor (Ed.).
70. Sirkar K.K., Prasad R. Protein ultrafiltration-some negelected considerations. Membrane Separations in Biotechnology 1986, 27-59. Marcel Dekker Inc., New York. W.C. McGregor (Ed.).
71. García-García J.C., Montero C., Rodríguez M., Soto A., Redondo M., Valdés M., Méndez L., Fuente j.de la Fuente Effect of particulation on the immunogenic and protective properties of the recombinant Bm86 antigen expressed in Pichia pastoris. Vaccine 1998, 16:374-380.
72. Rodríguez Valle M., Méndez L., Valdez M., Redondo M., Espinosa C.M., Vargas M., Cruz R.L., Barrios H.P., Seoane G., Ramírez E.S., Boué O., Vigil J.L., Machado H., Nordelo C.B., Piñeiro M.J. Integrated control of Boophilus microplus ticks in Cuba based on vaccination with the anti-tick vaccine Gavac. Exp. Appl. Acarol. 2004, 34:375-382.
73. Boué O., Redondo M., Montero C., Rodríguez M., de la Fuente J. Reproductive and safety assessments of the vaccination with Gavac™ against the cattle tick (Boophilus microplus). Theriogenology 1999, 51:1547-1554.
74. Cobon G., Hungerford J., Woodrow M., Smith D., Willadsen P. Vaccination against Boophilus microplus: the Australian field experience. Recombinant Vaccines for the Control of Cattle Tick 1995, Elfos Scientiae, Havana, pp. 163-176. J. de la Fuente (Ed.).
75. Willadsen P., Bird P., Cobon G.S., Hungerford J. Commercialization of a recombinant vaccine against Boophilus microplus. Parasitology 1995, 110:S43-S50.
76. Jonsson N.N., Matschoss A.L., Pepper P., Green P.E., Albrecht M.S., Hungerford J., Ansell J. Evaluation of tick- GARD(PLUS), a novel vaccine against Boophilus microplus, in lactating Holstein-Friesian cows. Vet. Parasitol. 2000, 88:275-285.
77. Fiske J.M., Ross A., VanDerMeid R.K., McMichael J.C., Arumugham R. Method for reducing endotoxin in Moraxella catarrhalis UspA2 protein preparations. J. Chromatogr. B 2001, 753:269-278.
78. Schnaitman C.A. Effect of Ethylenediaminetetraacetic acid, Triton X-100 and Lysozyme on the morphology and chemical composition of isolated cell walls of Escherichia coli. J. Bacteriol. 1971, 108:553-563.
79. Reichelt P., Schwarz C., Donzeau M. Single step protocol to purify recombinant proteins with low endotoxin contents. Protein Expr. Purif. 2006, 46:483-488.
80. Wilson M.J., Haggart C.L., Gallagher S.P., Walsh D. Removal of tightly bound endotoxin from biological products. J. Biotechnol. 2001, 88:67-75.
81. Anspach F.B. Endotoxin removal by affinity sorbents. J. Biochem. Biophys. Methods 2001, 49:665-681.
82. Kang Y., Luo R.G. Chromatographic removal of endotoxin from haemoglobin preparations. Effects of solution conditions on endotoxin removal efficiency and protein recovery. J. Chromatogr. A 1998, 809:13-20.
83. Matsumae H., Minobe S., Kindan K., Watanabe T., Sato T., Tosa T. Specific renoval of endotoxin from protein solutions by immobilized histidine. Biotechnol. Appl. Biochem. 1990, 12:129-140.
84. Aida Y., Pabst M.J. Removal of endotoxin from protein solutions by phase separation using Triton X-114. J. Immunol. Methods 1990, 14:191-195.
85. Liu S., Tobias R., McClure S., Styba Y., Shi Q., Jackowski G. Removal of endotoxin from recombinant protein preparations. Clin. Biochem. 1997, 30:455-463.
86. Liu C.L., Nikas Y.J., Blankschtein D. Novel bioseparations using two-phase aqueous micellar systems. Biotechnol. Bioeng. 1996, 52:185-192.